Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2023
February
01
Sepsis increases heart failure, rehospitalization risks following hospital discharge
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M
Sherlock Biosciences acquires Sense Biodetection to drive CRISPR-based test adoption
University of Missouri researchers say specific long-COVID symptoms fewer than expected
AstraZeneca, Capitainer to develop biomarker protocols using at-home patient sampling device
Study suggests immune response to anticancer checkpoint inhibitors unaffected by COVID-19 vaccination
Guardant NSCLC biomarker test to incorporate Lunit’s AI-based scoring algorithm
Genetic Technologies, Qiagen forming strategic alliance
Page 1 of 1